Загрузка...
Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters
OBJECTIVE: Hydroxyurea has proven laboratory and clinical therapeutic benefits for sickle cell anemia (SCA) and other diseases, yet many questions remain regarding its in vivo pharmacokinetic and pharmacodynamic profiles. Previous reports suggest that hydroxyurea passively diffuses across cells, but...
Сохранить в:
| Опубликовано в: : | Exp Hematol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739778/ https://ncbi.nlm.nih.gov/pubmed/21256917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2011.01.004 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|